Correlation Between SeqLL and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both SeqLL and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SeqLL Inc and NLS Pharmaceutics AG, you can compare the effects of market volatilities on SeqLL and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and NLS Pharmaceutics.

Diversification Opportunities for SeqLL and NLS Pharmaceutics

0.0

Correlation Coefficient

SeqLL  NLS Pharmaceutics

Pay attention - limited upside

The 3 months correlation between SeqLL and NLS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of SeqLL i.e., SeqLL and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between SeqLL and NLS Pharmaceutics

If you would invest  2.00  in NLS Pharmaceutics AG on December 26, 2024 and sell it today you would lose (1.20) from holding NLS Pharmaceutics AG or give up 60.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

SeqLL Inc  vs.  NLS Pharmaceutics AG

SeqLL Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days SeqLL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, SeqLL is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

NLS Pharmaceutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SeqLL and NLS Pharmaceutics

The main advantage of trading using opposite SeqLL and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind SeqLL Inc and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.